-
公开(公告)号：US20180050086A1
公开(公告)日：2018-02-22
申请号：US15798576
申请日：2017-10-31
Applicant: Wisconsin Alumni Research Foundation
Inventor： Denise M. Ney , Eric Chi-Liang Yen , David W. Nelson , Patrick Solverson
CPC classification number: A61K38/1709 , A23L33/18 , A23V2002/00 , A61K9/0053 , A61K38/018 , A61K38/22 , A23V2200/306 , A23V2200/332 , A23V2250/55
Abstract: Methods for improving the health of a female human or non-human animal are disclosed. The methods include the step of administering to the animal compositions including an effective amount of glycomacropeptide (GMP) for effectuating the methods. Specifically, the methods can be used to increase the rate of fat metabolism or fat oxidation, decrease percentage of body fat, increase the rate of bone mineralization, increase bone mineral content, increase bone mineral density, and/or increase bone strength in the animal.GMP-containing compositions can be used according to the disclosed methods to treat obesity and related metabolic conditions, or to treat or prevent osteoporosis, osteopenia, and other conditions related to loss of bone mineral content or bone strength.
-
公开(公告)号：US09180168B2
公开(公告)日：2015-11-10
申请号：US13755893
申请日：2013-01-31
Applicant: Wisconsin Alumni Research Foundation
Inventor： Denise M. Ney , Eric Chi-Liang Yen , David W. Nelson , Patrick Solverson
CPC classification number: A61K38/1709 , A23L33/18 , A23V2002/00 , A61K9/0053 , A61K38/018 , A61K38/22 , A23V2200/306 , A23V2200/332 , A23V2250/55
Abstract: Methods for improving the health of a female human or non-human animal are disclosed. The methods include the step of administering to the animal compositions including an effective amount of glycomacropeptide (GMP) for effectuating the methods. Specifically, the methods can be used to increase the rate of fat metabolism or fat oxidation, decrease percentage of body fat, increase the rate of bone mineralization, increase bone mineral content, increase bone mineral density, and/or increase bone strength in the animal.GMP-containing compositions can be used according to the disclosed methods to treat obesity and related metabolic conditions, or to treat or prevent osteoporosis, osteopenia, and other conditions related to loss of bone mineral content or bone strength.
Abstract translation: 公开了改善女性人或非人动物健康的方法。 所述方法包括向动物组合物施用包括有效量的糖巨肽（GMP）用于实施该方法的步骤。 具体来说，该方法可用于增加动物的脂肪代谢或脂肪氧化速率，降低体脂肪的百分比，增加骨矿化速率，增加骨矿物质含量，增加骨矿物质密度和/或增加骨强度 。 根据所公开的方法可以使用含GMP的组合物来治疗肥胖症和相关的代谢病症，或用于治疗或预防与骨矿物质含量或骨强度相关的骨质疏松症，骨质减少症和其它病症。
-
公开(公告)号：US20160022770A1
公开(公告)日：2016-01-28
申请号：US14872641
申请日：2015-10-01
Applicant: Wisconsin Alumni Research Foundation
Inventor： Denise M. Ney , Eric Chi-Liang Yen , David W. Nelson , Patrick Solverson
CPC classification number: A61K38/1709 , A23L33/18 , A23V2002/00 , A61K9/0053 , A61K38/018 , A61K38/22 , A23V2200/306 , A23V2200/332 , A23V2250/55
Abstract: Methods for improving the health of a female human or non-human animal are disclosed. The methods include the step of administering to the animal compositions including an effective amount of glycomacropeptide (GMP) for effectuating the methods. Specifically, the methods can be used to increase the rate of fat metabolism or fat oxidation, decrease percentage of body fat, increase the rate of bone mineralization, increase bone mineral content, increase bone mineral density, and/or increase bone strength in the animal.GMP-containing compositions can be used according to the disclosed methods to treat obesity and related metabolic conditions, or to treat or prevent osteoporosis, osteopenia, and other conditions related to loss of bone mineral content or bone strength.
-
公开(公告)号：US20130196905A1
公开(公告)日：2013-08-01
申请号：US13755893
申请日：2013-01-31
Applicant: Wisconsin Alumni Research Foundation
Inventor： Denise M. Ney , Eric Chi-Liang Yen , David W. Nelson , Patrick Solverson
CPC classification number: A61K38/1709 , A23L33/18 , A23V2002/00 , A61K9/0053 , A61K38/018 , A61K38/22 , A23V2200/306 , A23V2200/332 , A23V2250/55
Abstract: Methods for improving the health of a female human or non-human animal are disclosed. The methods include the step of administering to the animal compositions including an effective amount of glycomacropeptide (GMP) for effectuating the methods. Specifically, the methods can be used to increase the rate of fat metabolism or fat oxidation, decrease percentage of body fat, increase the rate of bone mineralization, increase bone mineral content, increase bone mineral density, and/or increase bone strength in the animal.GMP-containing compositions can be used according to the disclosed methods to treat obesity and related metabolic conditions, or to treat or prevent osteoporosis, osteopenia, and other conditions related to loss of bone mineral content or bone strength.
Abstract translation: 公开了改善女性人或非人动物健康的方法。 所述方法包括向动物组合物施用包括有效量的糖巨肽（GMP）用于实施该方法的步骤。 具体来说，该方法可用于增加动物的脂肪代谢或脂肪氧化速率，降低体脂肪的百分比，增加骨矿化速率，增加骨矿物质含量，增加骨矿物质密度和/或增加骨强度 。 根据所公开的方法可以使用含GMP的组合物来治疗肥胖症和相关的代谢病症，或用于治疗或预防与骨矿物质含量或骨强度相关的骨质疏松症，骨质减少症和其它病症。
-
-
-
Search Results
4
records
(took 0.014 seconds)
